0001493152-21-023888.txt : 20210927
0001493152-21-023888.hdr.sgml : 20210927
20210927171535
ACCESSION NUMBER: 0001493152-21-023888
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210827
FILED AS OF DATE: 20210927
DATE AS OF CHANGE: 20210927
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Diamantis Christopher Eric
CENTRAL INDEX KEY: 0001578723
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35141
FILM NUMBER: 211282695
MAIL ADDRESS:
STREET 1: 400 SOUTH AUSTRALIAN AVENUE
STREET 2: 8TH FLOOR
CITY: WEST PALM BEACH
STATE: FL
ZIP: 33401
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Rennova Health, Inc.
CENTRAL INDEX KEY: 0000931059
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062]
IRS NUMBER: 680370244
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 S. AUSTRALIAN AVENUE, SUITE 800
CITY: WEST PALM BEACH
STATE: FL
ZIP: 33401
BUSINESS PHONE: 561-855-1626
MAIL ADDRESS:
STREET 1: 400 S. AUSTRALIAN AVENUE, SUITE 800
CITY: WEST PALM BEACH
STATE: FL
ZIP: 33401
FORMER COMPANY:
FORMER CONFORMED NAME: CollabRx, Inc.
DATE OF NAME CHANGE: 20120926
FORMER COMPANY:
FORMER CONFORMED NAME: TEGAL CORP /DE/
DATE OF NAME CHANGE: 19950918
4
1
ownership.xml
X0306
4
2021-08-27
0
0000931059
Rennova Health, Inc.
RNVA
0001578723
Diamantis Christopher Eric
1143 GLENDALE LANE
NASHVILLE,
TN
37204
0
0
1
0
Common Stock
2021-08-27
4
J
0
95000000
A
95450000
D
Warrants to Purchase Common Stock
0.007
2021-08-27
4
J
0
47500000
A
2021-08-27
2024-08-27
Common Stock
47500000
47500000
D
Series M Convertible Redeemable Preferred Stock
2021-08-27
4
J
0
570
D
Common Stock
20180
D
On August 27, 2021, pursuant to the terms of an Exchange Agreement with the Issuer, Mr. Diamantis exchanged 570 shares of Series M Redeemable Convertible Preferred Stock of the Issuer (the "Series M Preferred Stock") for 95,000,000 shares of Common Stock and Warrants to purchase 47,500,000 shares of Common Stock.
The exercise of the Warrants and the conversion of the Series M Preferred Stock are each subject to ownership blockers of 4.99%. As a result, they are not exercisable or convertible as of August 27, 2021. The Series M Preferred Stock has no stated maturity date.
The conversion price of the Series M Preferred Stock fluctuates with the price of the Common Stock.
/s/ Christopher E. Diamantis
2021-09-27